TXN and Parkinson disease: ASK-1 is complexed by Thioredoxin [65], and this binding prevents apoptosis, as reported in an in vitro model of Parkinson’s disease, where Thioredoxin shows inhibition of the proapoptotic protein ASK-1, and where compounds that enhance this binding act as cell protectors [66].